Belite Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Belite Bio, Inc (BLTE) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents31.6888.1642.0917.3425.62
Short-Term Investments113.470.000.000.000.00
Cash & Short-Term Investments145.1588.1642.0917.3425.62
Accounts Receivable0.580.870.000.020.00
Inventory0.000.000.000.000.00
Other Current Assets1.330.920.700.060.01
Total Current Assets147.0789.9442.8117.4325.67
Non-Current Assets
Property, Plant & Equipment (Net)0.971.301.350.090.05
Intangible Assets0.033.300.030.000.00
Other Non-Current Assets4.060.060.120.010.03
Total Non-Current Assets5.064.701.470.920.00
Total Assets152.1394.6444.2718.3525.74
Current Liabilities
Accounts Payable0.013.330.000.070.00
Short-Term Debt0.280.000.000.000.00
Accrued Liabilities5.472.451.831.410.97
Other Current Liabilities0.300.150.070.100.01
Total Current Liabilities6.053.632.101.640.97
Non-Current Liabilities
Long-Term Debt0.260.580.670.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.260.580.6731.810.00
Total Liabilities6.314.212.7733.440.97
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-107.65-71.50-39.87-27.22-17.56
Accumulated Other Comprehensive Income-0.66-0.37-0.39-0.20-0.04
Additional Paid-in Capital254.13162.3181.7612.330.00
Shares Outstanding31.8329.1524.9024.100.00
Total Stockholders' Equity145.8290.4341.50-15.0924.77
Total Liabilities & Equity152.1394.6444.2718.350.00